Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
31.15
+0.58 (1.90%)
Feb 3, 2026, 3:00 PM CST
83.56%
Market Cap12.70B +78.5%
Revenue (ttm)850.99M +29.7%
Net Income7.28M
EPS0.02
Shares Out407.81M
PE Ratio1,744.50
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,521,358
Average Volume14,505,063
Open30.61
Previous Close30.57
Day's Range30.33 - 31.24
52-Week Range14.86 - 44.99
Beta0.75
RSI42.68
Earnings DateMar 31, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 973
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements